Search hospitals > Colorado > Durango
Southwest Retina Research Center
Claim this profileDurango, Colorado 81303
Conducts research for Age-Related Macular Degeneration
Conducts research for Macular Degeneration
Conducts research for Retinal Disease
Conducts research for Retinal Degeneration
Conducts research for None
3 reported clinical trials
0 medical researchers
Summary
Southwest Retina Research Center is a medical facility located in Durango, Colorado. This center is recognized for care of Age-Related Macular Degeneration, Macular Degeneration, Retinal Disease, Retinal Degeneration, None and other specialties. Southwest Retina Research Center is involved with conducting 3 clinical trials across 11 conditions. There are 0 research doctors associated with this hospital, such as .Area of expertise
1Age-Related Macular Degeneration
Stage I
Stage II
CFI rare variant positive
2Macular Degeneration
Stage I
Stage II
CFI rare variant positive
Top PIs
Clinical Trials running at Southwest Retina Research Center
Age-Related Macular Degeneration
Macular Degeneration
Choroidal Neovascularization
Retinal Degeneration
Retinal Disease
None
Choroidal neovascularization
Wet AMD
RGX-314 Gene Therapy
for Age-Related Macular Degeneration
This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.
Recruiting2 awards Phase 32 criteria
RGX-314 Gene Therapy
for Wet Age-Related Macular Degeneration
This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. It aims to help the eye make its own medicine to stop harmful blood vessels from causing vision loss. This could reduce the need for regular injections. RGX-314 modifies the retina's cells to create a treatment that may only be needed once.
Recruiting1 award Phase 2 & 36 criteria
Pozelimab + Cemdisiran
for Macular Degeneration
This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atrophy (GA) caused by Age-related Macular Degeneration (AMD). Geographic atrophy is a medical term that refers to later-stage cases of AMD which is an eye condition affecting central vision (what one sees straight ahead). The purpose of this study is to evaluate the progression rate of Geographic Atrophy in eyes of patients treated with cemdisiran alone or in combination with pozelimab compared to those treated with placebo. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug(s) * How much study drug(s) are in the blood at different times * Whether the body makes antibodies against the study drug(s) (which could make the study drug(s) less effective or could lead to side effects)
Recruiting1 award Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Southwest Retina Research Center?
Southwest Retina Research Center is a medical facility located in Durango, Colorado. This center is recognized for care of Age-Related Macular Degeneration, Macular Degeneration, Retinal Disease, Retinal Degeneration, None and other specialties. Southwest Retina Research Center is involved with conducting 3 clinical trials across 11 conditions. There are 0 research doctors associated with this hospital, such as .
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.